Requirement of Interleukin‐17A for Systemic Anti– Candida albicans Host Defense in Mice
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
T cells are required for normal host defense against fungal infection, and individuals with T cell-deficiency syndromes are highly susceptible to fungal pathogens. Interleukin (IL)-17A is a proinflammatory cytokine that interconnects myeloid and lymphoid host defense. The role of murine (m) IL-17A/mIL-17A receptor (R) interactions was evaluated in a murine model of systemic candidiasis. In response to systemic challenge with Candida albicans, expression of mIL-17A was induced, and IL-17AR knockout (IL-17AR(-/-)) mice had dose-dependent, substantially reduced survival. Fungal burden in the kidneys of IL-17AR(-/-) mice was dramatically increased (25-fold at 96 h). In IL-17AR(-/-) mice, both mobilization of peripheral neutrophils and their influx to infected organs were significantly impaired and delayed. In vivo expression of mIL-17A protected normal mice from a lethal dose of C. albicans (100% at day 7 and 65% at day 42). The data suggest that the mIL-17A/mIL-17AR system is required for normal fungal host defense in vivo. IL-17A could have potential as a therapeutic cytokine for systemic C. albicans infections in immunocompromised patients with cancer or advanced acquired immunodeficiency syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Confirming previous reports, IL-17RA-/- mice demonstrated significantly increased kidney fungal burden in comparison to WT following infection with C. albicans (CAF2-1 or SC5314) (Fig 1A) [14,16,33].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
In the citing paper
“IL-17RA-/-, IL-17RC-/-, RORγt-/- and IL-17A-/- mice are all susceptible to systemic C. albicans infection [14–17].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
In the citing paper
“During candidiasis, IL-17 is rapidly upregulated in the kidney, but its function in that organ is unknown [14].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
In the citing paper
“IL-17 is a key mediator of defense against candidiasis.”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
In the citing paper
“In recent years, considerable data have implicated IL-17 in immunity against disseminated candidiasis [14–16].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [14]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Ye, P., Rodriguez, F. H., Kanaly, S., Stocking, K. L., Schurr, J., Schwarzenberger, P., Oliver, P., Huang, W., Zhang, P., Zhang, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.519 · Cited by 1,521
Self-citationTrends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997
McNeil, M. M., Nash, S. L., Hajjeh, R. A., Phelan, M. A., Conn, L. A., Plikaytis, B. D., & Warnock, D. W. (2001) · Clinical Infectious Diseases · doi:10.1086/322606 · Cited by 657 · cited 1×
“suppressive cancer chemotherapy, especially if this treatment is followed by prolonged periods of neutropenia, such as seen in bone marrow transplantation [1, 2].”
BackgroundIL-17: prototype member of an emerging cytokine family
Aggarwal, S., & Gurney, A. L. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.1.1 · Cited by 597 · cited 1×
“tem, because of its unique effects [14].”
Interleukin-17 and Lung Host Defense against Klebsiella pneumoniae Infection
Ye, P., Garvey, P. B., Zhang, P., Nelson, S., Bagby, G., Summer, W. R., Schwarzenberger, P., Shellito, J. E., & Kolls, J. K. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.3.4424 · Cited by 461 · cited 2×
“Although statistically significant, this finding was less pronounced than that observed in our previous studies of gram-negative bacteria challenge, in which IL17AR / mice failed entirely to mount a peripheral neutrophil response [8, 9].”
ResultSelf-citationSchwarzenberger, P., La Russa, V., Miller, A., Ye, P., Huang, W., Zieske, A., Nelson, S., Bagby, G. J., Stoltz, D., Mynatt, R. L., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6383 · Cited by 325 · cited 5×
“neutrophils and their precursors [7, 9] (data not shown).”
BackgroundMethodInfluentialSelf-citationAntibody response that protects against disseminated candidiasis
Han, Y., & Cutler, J. E. (1995) · Infection and Immunity · doi:10.1128/iai.63.7.2714-2719.1995 · Cited by 308 · cited 1×
“teractions between T cells and phagocytes and have reported that this phenomenon directly augments fungicidal properties [21-24].”
BackgroundCAUSES OF DEATH IN ADULTS WITH ACUTE LEUKEMIA
CHANG, H.-Y., RODRIGUEZ, V., NARBONI, G., BODEY, G. P., LUNA, M. A., & FREIREICH, E. J. (1976) · Medicine · doi:10.1097/00005792-197605000-00005 · Cited by 301 · cited 2×
“individuals [1, 5].”
Schwarzenberger, P., Huang, W., Ye, P., Oliver, P., Manuel, M., Zhang, Z., Bagby, G., Nelson, S., & Kolls, J. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4783 · Cited by 277 · cited 1×
“mIL-17A was found to exert significant effects on neutrophils and its precursors, not directly, but, to a large extent, via the induction and release of secondary or downstream cytokines from stromal cells [7, 15].”
BackgroundSelf-citationInfectious Complications of Chronic Lymphocytic Leukemia
WADHWA, P., & MORRISON, V (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.12.013 · Cited by 276 · cited 1×
“related to clinical outcomes [5, 6].”
Bacteremia and Fungemia in Patients with the Acquired Immunodeficiency Syndrome
WHIMBEY, E., GOLD, J. W. M., POLSKY, B., DRYJANSKI, J., HAWKINS, C., BLEVINS, A., BRANNON, P., KIEHN, T. E., BROWN, A. E., & ARMSTRONG, D. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-4-511 · Cited by 239 · cited 3×
“The data are encouraging for pursuing further development of mIL-17A in fungal infections, which could benefit immunocompromised individuals, especially patients with cancer or AIDS.”
Background
Cited by
Items 101–200 of 858
Minegishi, Y., Saito, M., Nagasawa, M., Takada, H., Hara, T., Tsuchiya, S., Agematsu, K., Yamada, M., Kawamura, N., Ariga, T., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082767 · Cited by 243
Eyerich, K., Foerster, S., Rombold, S., Seidl, H.-P., Behrendt, H., Hofmann, H., Ring, J., & Traidl-Hoffmann, C. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.139 · Cited by 243
“…of IL-17 and expression of CCR6 (Harrington, 2006; Singh et al., 2008), has been found, aside its involvement in autoimmune diseases and immunosurveillance, to be involved in host defense against Candida in mice and humans (Huang et al., 2004; Acosta-Rodriguez et al., 2007b; Bettelli et al., 2007).”
BackgroundCommensal Candida albicans Positively Calibrates Systemic Th17 Immunological Responses
Shao, T.-Y., Ang, W. X. G., Jiang, T. T., Huang, F. S., Andersen, H., Kinder, J. M., Pham, G., Burg, A. R., Ruff, B., Gonzalez, T., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.02.004 · Cited by 237
“albicans infection using IL-17A-or IL-17 receptor-deficient mice (Huang et al., 2004; Saijo et al., 2010; van de Veerdonk et al., 2010), others have shown completely non-essential roles for these molecules (De Luca et al.”
BackgroundIL-17 and IL-22: siblings, not twins
Eyerich, S., Eyerich, K., Cavani, A., & Schmidt-Weber, C. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.06.004 · Cited by 236
Precarious Balance: Th17 Cells in Host Defense
Peck, A., & Mellins, E. D. (2010) · Infection and Immunity · doi:10.1128/iai.00929-09 · Cited by 236
“pergillus, among others, exacerbates pathology characterized by inadequate neutrophil recruitment, increased fungal burden, and reduced chemokine and antimicrobial expression (13, 35, 77, 95).”
BackgroundBacterial Sensing, Cell Signaling, and Modulation of the Immune Response During Sepsis
Salomao, R., Brunialti, M. K. C., Rapozo, M. M., Baggio-Zappia, G. L., Galanos, C., & Freudenberg, M. (2012) · Shock · doi:10.1097/shk.0b013e318262c4b0 · Cited by 233
T Cell–Mediated Host Immune Defenses in the Lung
Chen, K., & Kolls, J. K. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100019 · Cited by 233
Regulation of interleukin‐12/interleukin‐23 production and the T‐helper 17 response in humans
Lyakh, L., Trinchieri, G., Provezza, L., Carra, G., & Gerosa, F. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00700.x · Cited by 227
Wüthrich, M., Gern, B., Hung, C. Y., Ersland, K., Rocco, N., Pick-Jacobs, J., Galles, K., Filutowicz, H., Warner, T., Evans, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43984 · Cited by 228
“The role of Th17 cells has been studied mainly during primary fungal infection (18, 20, 23, 31).”
Dectin-1 and Dectin-2 in innate immunity against fungi
Saijo, S., & Iwakura, Y. (2011) · International Immunology · doi:10.1093/intimm/dxr046 · Cited by 226
Wüthrich, M., Deepe, G. S., & Klein, B. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074958 · Cited by 224
How Diverse--CD4 Effector T Cells and their Functions
Wan, Y. Y., & Flavell, R. A. (2009) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjp001 · Cited by 222
“, 2005), intravenous Candida albicans infection (Huang et al., 2004), and infection of the natural rodent pathogen Citrobacter rodentium in the gut (Mangan et al.”
BackgroundIL-6 Promotes NK Cell Production of IL-17 during Toxoplasmosis
Passos, S. T., Silver, J. S., O’Hara, A. C., Sehy, D., Stumhofer, J. S., & Hunter, C. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901843 · Cited by 223
“Klebsiella pneumoniae (18), Candida albicans (19), and Toxo-”
BackgroundThe role of Syk/CARD9 coupled C-type lectins in antifungal immunity
Drummond, R. A., Saijo, S., Iwakura, Y., & Brown, G. D. (2011) · European Journal of Immunology · doi:10.1002/eji.201041252 · Cited by 221
From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited
Boniface, K., Blom, B., Liu, Y., & De Waal Malefyt, R. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00714.x · Cited by 218
“monocytogenes (106, 108, 109), and IL-22 is critical for host defense against Citrobacter rodentium infection (110).”
BackgroundKagami, S., Rizzo, H. L., Kurtz, S. E., Miller, L. S., & Blauvelt, A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001153 · Cited by 216
“IL-17AR–deficient mice had reduced survival rates after systemic Candida challenge (36).”
Dhodapkar, K. M., Barbuto, S., Matthews, P., Kukreja, A., Mazumder, A., Vesole, D., Jagannath, S., & Dhodapkar, M. V. (2008) · Blood · doi:10.1182/blood-2008-03-143222 · Cited by 216
Interleukin-17 and systemic lupus erythematosus: current concepts
Nalbandian, A., Crispín, J. C., & Tsokos, G. C. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03944.x · Cited by 216
Interleukin-1 as Innate Mediator of T Cell Immunity
Van Den Eeckhout, B., Tavernier, J., & Gerlo, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.621931 · Cited by 213
IL-17–producing T cells in lung immunity and inflammation
Nembrini, C., Marsland, B. J., & Kopf, M. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.03.033 · Cited by 210
Yi, T., Zhao, D., Lin, C.-L., Zhang, C., Chen, Y., Todorov, I., LeBon, T., Kandeel, F., Forman, S., & Zeng, D. (2008) · Blood · doi:10.1182/blood-2007-12-126987 · Cited by 207
Adaptive immune responses to Candida albicans infection
Richardson, J. P., & Moyes, D. L. (2015) · Virulence · doi:10.1080/21505594.2015.1004977 · Cited by 204
“Mice unable to produce IL23 are highly susceptible to OPC,(46) while mice lacking IL-17 receptor-A (IL-17RA¡/-) or IL-23p19 (IL-23p19¡/-) have increased susceptibility to both OPC and systemic candidiasis.(36,47) Moreover, IL-17RC¡/- mice (deficient in the second IL17 receptor chain) are also susceptible to OPC.”
BackgroundT cell pathology in skin inflammation
Sabat, R., Wolk, K., Loyal, L., Döcke, W.-D., & Ghoreschi, K. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00742-7 · Cited by 201
IL-17 regulates systemic fungal immunity by controlling the functional competence of NK cells
Bär, E., Whitney, P. G., Moor, K., Reis e Sousa, C., & LeibundGut-Landmann, S. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.002 · Cited by 197
“In agreement with Huang et al. (2004), we found that Il17ra / mice died rapidly in response to systemic infection with Candida albicans and that this was associated with massive fungal burden in the kidneys at 3 days postinfection when compared to C57BL/6 or 129wild-type controls or heterozygous…”
BackgroundResultInfluentialNew Insights in the Immunologic Basis of Psoriasis
Nograles, K. E., Davidovici, B., & Krueger, J. G. (2010) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2010.03.001 · Cited by 196
Klatt, N. R., Estes, J. D., Sun, X., Ortiz, A. M., Barber, J. S., Harris, L. D., Cervasi, B., Yokomizo, L. K., Pan, L., Vinton, C. L., et al. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.38 · Cited by 196
Clinical Manifestations, Etiology, and Pathogenesis of the Hyper-IgE Syndromes
Freeman, A. F., & Holland, S. M. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819dc8c5 · Cited by 195
“The significance of diminished IL-17 production in humans is still being elucidated, but mice that are deficient in IL-17 are prone to Candida and Klebsiella infections (38,39).”
Cheng, S.-C., van de Veerdonk, F. L., Lenardon, M., Stoffels, M., Plantinga, T., Smeekens, S., Rizzetto, L., Mukaremera, L., Preechasuth, K., Cavalieri, D., et al. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1210702 · Cited by 191
“The importance of Th17 responses for antifungal host defense is supported by two additional lines of evidence: IL-17 is important for host defense against systemic fungal infection [29, 30], and IL-17 has been shown to be a crucial component of mucosal antifungal defense in a murine experimental model [4].”
BackgroundCancers Related to Immunodeficiencies: Update and Perspectives
Mortaz, E., Tabarsi, P., Mansouri, D., Khosravi, A., Garssen, J., Velayati, A., & Adcock, I. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00365 · Cited by 190
Tiringer, K., Treis, A., Fucik, P., Gona, M., Gruber, S., Renner, S., Dehlink, E., Nachbaur, E., Horak, F., Jaksch, P., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201206-1150oc · Cited by 187
Tomalka, J., Ganesan, S., Azodi, E., Patel, K., Majmudar, P., Hall, B. A., Fitzgerald, K. A., & Hise, A. G. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002379 · Cited by 184
“Recent studies have shown that the innate inflammatory mileu is critical for effective neutrophil activity against fungal pathogens including IL-6, GM-CSF, and IL-17 responses [38,41,42,50,51].”
BackgroundThe interleukin‐23 axis in intestinal inflammation
Ahern, P. P., Izcue, A., Maloy, K. J., & Powrie, F. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00705.x · Cited by 185
“This property of IL-17 renders it important in host defense against a number of infections including Klebsiella pneumoniae (103, 105), Candida albicans (106), and Toxoplasma gondii (107).”
BackgroundCandida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework
Jabra-Rizk, M. A., Kong, E. F., Tsui, C., Nguyen, M. H., Clancy, C. J., Fidel, P. L., & Noverr, M. (2016) · Infection and Immunity · doi:10.1128/iai.00469-16 · Cited by 182
“In fact, animal studies have shown that infection of IL-17Ra knockouts results in greater mortality, higher fungal burdens, and significantly decreased neutrophil recruitment in an HDC model of infection (75, 76).”
BackgroundSelf-citationNanzer, A. M., Chambers, E. S., Ryanna, K., Richards, D. F., Black, C., Timms, P. M., Martineau, A. R., Griffiths, C. J., Corrigan, C. J., & Hawrylowicz, C. M. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.03.037 · Cited by 181
“Mouse models demonstrate that animals deficient in IL-17A or IL-17RA are highly susceptible to infection with mucosal pathogens such as Klebsiella pneumoniae, and Candida albicans (12, 13).”
BackgroundThe dual nature of TH17 cells: shifting the focus to function
O'Connor, W., Zenewicz, L. A., & Flavell, R. A. (2010) · Nature Immunology · doi:10.1038/ni.1882 · Cited by 179
Candida Urinary Tract Infection: Pathogenesis
Fisher, J. F., Kavanagh, K., Sobel, J. D., Kauffman, C. A., & Newman, C. A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir110 · Cited by 176
“Huang et al [25] noted the induction of murine IL-17A when animals were given doses of C.”
BackgroundChorioamnionitis and neonatal outcomes
Jain, V. G., Willis, K. A., Jobe, A., & Ambalavanan, N. (2022) · Pediatric Research · doi:10.1038/s41390-021-01633-0 · Cited by 174
El Malki, K., Karbach, S. H., Huppert, J., Zayoud, M., Reißig, S., Schüler, R., Nikolaev, A., Karram, K., Münzel, T., Kuhlmann, C. R. W., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.318 · Cited by 174
“It was shown that in IL-17RA KO mice both mobilization of peripheral neutrophils and their influx to infected organs is significantly impaired and delayed (Huang et al., 2004).”
BackgroundInterleukin-17 in inflammatory skin disorders
van Beelen, A. J., Teunissen, M. B., Kapsenberg, M. L., & de Jong, E. C. (2007) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e3282ef869e · Cited by 175
Sarma, J. D., Ciric, B., Marek, R., Sadhukhan, S., Caruso, M. L., Shafagh, J., Fitzgerald, D. C., Shindler, K. S., & Rostami, A. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-14 · Cited by 174
“Recently it has been demonstrated in infectious models in which neutrophils are crucial for host defense, that IL-17RA deficiency results in reduced chemokine levels and reduced neutrophil numbers, and increased susceptibility to infection [11,12].”
Advances in understanding the anti-inflammatory properties of IL-27
Stumhofer, J. S., & Hunter, C. A. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.01.011 · Cited by 172
Loures, F. V., Pina, A., Felonato, M., & Calich, V. L. G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801599 · Cited by 172
“These data are consistent with previous findings in murine candidiasis describing a more severe systemic infection associated with deficient IL-17 production and impaired influx of neutrophils to infected organs (53) However, as described in other models of prevalent Th17 immunity, we believe that PMN cells exerted a…”
ResultThe mucosal immune system in the oral cavity—an orchestra of T cell diversity
Wu, R.-Q., Zhang, D.-F., Tu, E., Chen, Q.-M., & Chen, W. (2014) · International Journal of Oral Science · doi:10.1038/ijos.2014.48 · Cited by 171
The Role of Interleukin 17 in Tumour Proliferation, Angiogenesis, and Metastasis
Yang, B., Kang, H., Fung, A., Zhao, H., Wang, T., & Ma, D. (2014) · Mediators of Inflammation · doi:10.1155/2014/623759 · Cited by 169
El Hed, A., Khaitan, A., Kozhaya, L., Manel, N., Daskalakis, D., Borkowsky, W., Valentine, F., Littman, D. R., & Unutmaz, D. (2010) · The Journal of Infectious Diseases · doi:10.1086/651021 · Cited by 170
“associated opportunistic infections [11, 13].”
Immunity to infection in IL‐17‐deficient mice and humans
Cypowyj, S., Picard, C., Maródi, L., Casanova, J., & Puel, A. (2012) · European Journal of Immunology · doi:10.1002/eji.201242605 · Cited by 168
Animal models of mucosal Candida infection
Naglik, J. R., Fidel, P. L., & Odds, F. C. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01160.x · Cited by 169
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript resistance pathway (Zelante et al., 2007; Huang et al., 2004).”
BackgroundSelf-citationCandida albicans and Candida glabrata : global priority pathogens
Katsipoulaki, M., Stappers, M. H. T., Malavia-Jones, D., Brunke, S., Hube, B., & Gow, N. A. R. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00021-23 · Cited by 180
Maitra, A., Shen, F., Hanel, W., Mossman, K., Tocker, J., Swart, D., & Gaffen, S. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611589104 · Cited by 165
Role of IL-17 in Psoriasis and Psoriatic Arthritis
Raychaudhuri, S. P. (2013) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-012-8307-1 · Cited by 160
“Mice deficient in IL-17 are associated with neutrophil defects leading to increased susceptibility to many extracellular pathogens, like Klebsiella pneumonia, Candida albicans and Toxoplasma gondii [33, 73–75].”
BackgroundHuang, H., Ostroff, G. R., Lee, C. K., Specht, C. A., & Levitz, S. M. (2010) · mBio · doi:10.1128/mbio.00164-10 · Cited by 160
Kerrigan, A. M., & Brown, G. D. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00882.x · Cited by 160
“In contrast, mice that are unable to mount Th17 responses are very susceptible to oropharyngeal candidiasis (185, 186).”
BackgroundIL-17 targeted therapies for psoriasis
Chiricozzi, A., & Krueger, J. G. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.806483 · Cited by 160
“, the production of antimicrobial peptides (AMPs) and neutrophil chemoattractants), poses IL-17 as the main driver of the immune response against extracellular bacterial (Klebsiella pneumoniae, Streptococcus pneumoniae), parasitic (Toxoplasma gondii) and fungal (Candida albicans) infections [36-39].”
STAT3 Hyper-IgE Syndrome—an Update and Unanswered Questions
Tsilifis, C., Freeman, A. F., & Gennery, A. R. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01051-1 · Cited by 159
IL-17 Is Necessary for Host Protection against Acute-Phase Trypanosoma cruzi Infection
Miyazaki, Y., Hamano, S., Wang, S., Shimanoe, Y., Iwakura, Y., & Yoshida, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0900047 · Cited by 156
“IL-17A induced during infection of bacteria and fungi and a protozoan parasite Toxoplasma gondii mobilizes neutrophils for elimination of the pathogens (28, 29, 31, 48).”
BackgroundCritical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection
Feinen, B., Jerse, A. E., Gaffen, S. L., & Russell, M. W. (2010) · Mucosal Immunology · doi:10.1038/mi.2009.139 · Cited by 158
Host responses to Candida albicans: Th17 cells and mucosal candidiasis
Conti, H. R., & Gaffen, S. L. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.03.013 · Cited by 154
“In 2004 (prior to the discovery of Th17 cells per se), the IL-17 receptor (IL-17RA, the common receptor for IL-17A and IL-17F) was reported to be necessary for host protection in the disseminated candidiasis mouse model [38], which was recently confirmed by an independent group [39].”
BackgroundAn update on the hyper-IgE syndromes
Yong, P. F., Freeman, A. F., Engelhardt, K. R., Holland, S., Puck, J. M., & Grimbacher, B. (2012) · Arthritis Research & Therapy · doi:10.1186/ar4069 · Cited by 154
Hu, Y., Ota, N., Peng, I., Refino, C. J., Danilenko, D. M., Caplazi, P., & Ouyang, W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903614 · Cited by 153
The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis
van de Veerdonk, F. L., Joosten, L. A. B., Shaw, P. J., Smeekens, S. P., Malireddi, R. K. S., van der Meer, J. W. M., Kullberg, B., Netea, M. G., & Kanneganti, T. (2011) · European Journal of Immunology · doi:10.1002/eji.201041226 · Cited by 151
Napolitani, G., Acosta‐Rodriguez, E. V., Lanzavecchia, A., & Sallusto, F. (2009) · European Journal of Immunology · doi:10.1002/eji.200838969 · Cited by 147
Designing polymeric particles for antigen delivery
Koker, S. D., Lambrecht, B. N., Willart, M. A. M., van Kooyk, Y., Grooten, J., Vervaet, C., Remon, J. P., & Geest, B. G. D. (2010) · Chemical Society Reviews · doi:10.1039/b914943k · Cited by 151
How Inflammasomes Inform Adaptive Immunity
Evavold, C. L., & Kagan, J. C. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.09.019 · Cited by 144
“Th17 cells are associated with defense against extracellular bacteria and fungal pathogens [67,68].”
Interleukin‐17: A New Paradigm in Inflammation, Autoimmunity, and Therapy
Kramer, J. M., & Gaffen, S. L. (2007) · Journal of Periodontology · doi:10.1902/jop.2007.060392 · Cited by 147
Li, X., Utomo, A., Cullere, X., Choi, M. M., Milner, D. A., Venkatesh, D., Yun, S.-H., & Mayadas, T. N. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.10.009 · Cited by 147
“For tissue neutrophil accumulation, an MPO assay was performed as previously described (Huang et al., 2004).”
MethodHuang, H., Ostroff, G. R., Lee, C. K., Wang, J. P., Specht, C. A., & Levitz, S. M. (2009) · Infection and Immunity · doi:10.1128/iai.00086-09 · Cited by 146
“Indeed, fungal infections are often associated with Th17-type responses (24, 27).”
BackgroundGarg, A. V., Amatya, N., Chen, K., Cruz, J. A., Grover, P., Whibley, N., Conti, H. R., Hernandez Mir, G., Sirakova, T., Childs, E. C., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.021 · Cited by 145
“albicans (Huang et al., 2004; Saijo et al., 2010), we postulated that elevated IL-17 signaling in Zc3h12a mice would improve fungal clearance.”
Klatt, N. R., Harris, L. D., Vinton, C. L., Sung, H. C., Briant, J. A., Tabb, B., Morcock, D. R., McGinty, J. W., Lifson, J. D., Lafont, B. A. P., et al. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.14 · Cited by 153
The IL‐17 pathway as a major therapeutic target in autoimmune diseases
Hu, Y., Shen, F., Crellin, N. K., & Ouyang, W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05825.x · Cited by 156
Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy
Huppler, A. R., Bishu, S., & Gaffen, S. L. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3893 · Cited by 143
“Similarly, immunity to dermal and disseminated candidiasis in mice is regulated by the IL-17 pathway [18,19].”
BackgroundInborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?
Puel, A., Picard, C., Cypowyj, S., Lilic, D., Abel, L., & Casanova, J.-L. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.06.009 · Cited by 140
Fungi in Gastrointestinal Tracts of Human and Mice: from Community to Functions
Li, J., Chen, D., Yu, B., He, J., Zheng, P., Mao, X., Yu, J., Luo, J., Tian, G., Huang, Z., et al. (2017) · Microbial Ecology · doi:10.1007/s00248-017-1105-9 · Cited by 152
Th17 cells in immunity and autoimmunity
Oukka, M. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.098004 · Cited by 166
Schulz, S. M., Kohler, G., Holscher, C., Iwakura, Y., & Alber, G. (2008) · International Immunology · doi:10.1093/intimm/dxn069 · Cited by 139
Mucosal Immunity and Candida albicans Infection
Moyes, D. L., & Naglik, J. R. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/346307 · Cited by 138
“The role of L-17 in antiCandida immunity is controversial with evidence to indicate that it both increases [65] and reduces [67, 68] C.”
BackgroundTh17 cytokines and vaccine-induced immunity
Lin, Y., Slight-Webb, S. R., & Khader, S. A. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0191-2 · Cited by 156
“Protection against the disseminated form of the disease caused by Candida requires IL-17-mediated recruitment and expansion of neutrophils for pathogen control [42].”
Development of an anti‐IL‐17A auto‐vaccine that prevents experimental auto‐immune encephalomyelitis
Uyttenhove, C., & Van Snick, J. (2006) · European Journal of Immunology · doi:10.1002/eji.200636662 · Cited by 138
Insight Into Non-Pathogenic Th17 Cells in Autoimmune Diseases
Wu, X., Tian, J., & Wang, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01112 · Cited by 136
“Moreover, IL-17AR-knockout mice are more susceptible to Candida albicans infection (43).”
BackgroundLindenstrøm, T., Woodworth, J. S., Dietrich, J., Aagaard, C., Andersen, P. L., & Agger, E. M. (2012) · Infection and Immunity · doi:10.1128/iai.00550-12 · Cited by 140
“Initially, Th17 cells were thought to be involved primarily in immunity to extracellular pathogens (21, 33, 56) and are especially important for resolving fungal infections (23, 53).”
BackgroundGaffen, S. L., Kramer, J. M., Yu, J. J., & Shen, F. (2006) · Vitamins and hormones · doi:10.1016/s0083-6729(06)74010-9 · Cited by 151
New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome
Conti, H. R., Baker, O., Freeman, A. F., Jang, W. S., Holland, S. M., Li, R. A., Edgerton, M., & Gaffen, S. L. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.5 · Cited by 133
Aguiló, N., Álvarez-Arguedas, S., Uranga, S., Marinova, D., Monzón, M., Badiola, J. J., & Martín, C. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv503 · Cited by 152
Braun, R. K., Ferrick, C., Neubauer, P. D., Sjoding, M. W., Sterner‐Kock, A., Kock, M., Putney, L. F., Ferrick, D. A., Hyde, D. M., & Love, R. B. (2008) · Inflammation · doi:10.1007/s10753-008-9062-6 · Cited by 145
Chamilos, G., Ganguly, D., Lande, R., Gregorio, J., Meller, S., Goldman, W. E., Gilliet, M., & Kontoyiannis, D. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012955 · Cited by 132
“deficient mice are susceptible to disseminated [10] and oropha-”
BackgroundImmune Interactions with Pathogenic and Commensal Fungi: A Two-Way Street
Underhill, D. M., & Pearlman, E. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.023 · Cited by 130
“Mice with deletions in either IL17a or IL17ra receptor are more susceptible to mucosal (oropharyngeal) and systemic candidiasis (Conti and Gaffen, 2015; Conti et al., 2009; Huang et al., 2004; Saijo et al., 2010).”
BackgroundMangalam, A. K., Taneja, V., & David, C. S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201891 · Cited by 132
“Mice with targeted defects in IL-17 receptors or IL-23p19 have shown increased tissue fungal burdens and reduced survival (29).”
BackgroundWong, H., & Hoeffer, C. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.04.010 · Cited by 129
“C. Th17 cells Th17 cells have pro-inflammatory actions that are normally beneficial to host defense (Cai et al., 2016; Chung et al., 2003; Conti et al., 2009; Huang et al., 2004; Huppler et al., 2014; Korn et al., 2009; Ye et al., 2001).”
BackgroundConti, H. R., Huppler, A. R., Whibley, N., & Gaffen, S. L. (2014) · Current Protocols in Immunology · doi:10.1002/0471142735.im1906s105 · Cited by 126
“Mice deficient in formation of IL-17-producing cells or in IL17 signaling are highly susceptible to disseminated, oral, and dermal candidiasis models (Huang et al., 2004; Conti et al., 2009; Ho et al., 2010; Kagami et al., 2010).”
BackgroundHepatitis C Virus-Specific Th17 Cells Are Suppressed by Virus-Induced TGF-β
Rowan, A. G., Fletcher, J. M., Ryan, E. J., Moran, B., Hegarty, J. E., O’Farrelly, C., & Mills, K. H. G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4485 · Cited by 131
“Th17 cells have also been shown to have a protective role in certain bacterial and fungal infections, where they promote chemokine and proinflammatory cytokine production and consequent recruitment and activation of neutrophils and macrophages (4, 12, 13, 32).”
BackgroundTh17 cell dynamics in HIV infection
Klatt, N. R., & Brenchley, J. M. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3283364846 · Cited by 151
The IL-17 Family Cytokines in Immunity and Disease
Pappu, R., Ramirez-Carrozzi, V. R., Ota, N., Ouyang, W., & Hu, Y. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9369-6 · Cited by 143
“Il17ra mice cannot induce the chemokines necessary for neutrophil recruitment and granulopoiesis, resulting in a failure to mobilize neutrophils to sites of infection [45, 104], rendering them susceptible to multiple types of infections, including parasitic, extracellular bacterial, and fungal pathogens [46, 105].”
BackgroundTh17 responses and host defense against microorganisms: an overview
Van De Veerdonk, F. L., Gresnigt, M. S., Kullberg, B. J., Van Der Meer, J. W. M., Joosten, L. A. B., & Netea, M. G. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.12.776 · Cited by 127
“Intra gastric Intranasal Pulmonary Pulmonary Brain Pulmonary Increased susceptibility in IL-17RA deficient mice (7) Deficient Th17 response in humans and mice leads to increased susceptibility to candidiasis (6, 11, 63, 64) IL-17 deficiency increases susceptibility to oropharyngal candidiasis in mice (8) Th17 response…”
BackgroundChapter 5 Emergence of the Th17 Pathway and Its Role in Host Defense
O’Quinn, D. B., Palmer, M. T., Lee, Y. K., & Weaver, C. T. (2008) · Advances in immunology · doi:10.1016/s0065-2776(08)00605-6 · Cited by 141
The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity
Song, X., He, X., Li, X., & Qian, Y. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.105 · Cited by 137
Sivick, K. E., Schaller, M. A., Smith, S. N., & Mobley, H. L. T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902386 · Cited by 137
Rapaka, R. R., Ricks, D. M., Alcorn, J. F., Chen, K., Khader, S. A., Zheng, M., Plevy, S., Bengtén, E., & Kolls, J. K. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100034 · Cited by 124
“In systemic infection with Candida albicans, IL-17 receptor–deficient mice had increased tissue fungal burdens and reduced survival, which appears related to neutrophil recruitment to infected tissues (Huang et al., 2004b).”
BackgroundChai, L. Y. A., Van De Veerdonk, F., Marijnissen, R. J., Cheng, S., Khoo, A. L., Hectors, M., Lagrou, K., Vonk, A. G., Maertens, J., Joosten, L. A. B., et al. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03211.x · Cited by 127
Murine Models of Candida Gastrointestinal Colonization and Dissemination
Koh, A. Y. (2013) · Eukaryotic Cell · doi:10.1128/ec.00196-13 · Cited by 125
“The interleukin 17A (IL-17A) receptor (IL-17RA) (89) and IL-22 (90) appear to be essential for host defense in disseminated C.”
BackgroundThe Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
Tsukazaki, H., & Kaito, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176401 · Cited by 152
Th17-stimulating Protein Vaccines Confer Protection against Pseudomonas aeruginosa Pneumonia
Wu, W., Huang, J., Duan, B., Traficante, D. C., Hong, H., Risech, M., Lory, S., & Priebe, G. P. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201202-0182oc · Cited by 124
Metadata
- Authors
- Huang, W., Na, L., Fidel, P. L., & Schwarzenberger, P.
- Affiliations
- Louisiana State University Health Sciences Center New Orleans (US)
- Corresponding author
- Huang, Weitao
- ORCID
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08
- Volume
- 190
- Issue
- 3
- Pages
- 624-631
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2112133235
- Cited by
- 859
- References
- 30
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 25 · 2023: 21 · 2022: 20 · 2021: 23 · 2020: 19 · 2019: 23 · 2018: 28 · 2017: 35 · 2016: 41 · 2015: 53 · 2014: 48 · 2013: 52 · 2012: 74
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA081125)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-17A, IL-17 receptor, Candida albicans, systemic candidiasis, neutrophil recruitment, T cell-dependent immunity, immunocompromised patients
- MeSH terms
- Animals, Candida albicans, Candidiasis, Disease Models, Animal, Humans, Kidney, Mice, Inbred C57BL, Recombinant Proteins, Receptors, Interleukin, Mice, Knockout, Interleukin-17, Mice, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.